1. Analysis of methylation and mRNA expression status ofFADD andFAS genes in patients with oral squamous cell carcinoma
- Author
-
Arsalan Augend, Eshagh Ali Saberi, Dor-Mohammad Kordi-Tamandani, Sara Jamali, and Mohammad-Ayoub Rigi-Ladez
- Subjects
Male ,Mrna expression ,Fas-Associated Death Domain Protein ,Odontología ,medicine.disease_cause ,urologic and male genital diseases ,Gene expression ,medicine ,Humans ,In patient ,FADD ,RNA, Messenger ,fas Receptor ,General Dentistry ,Gene ,Oral Medicine and Pathology ,biology ,Research ,Methylation ,DNA Methylation ,Middle Aged ,CIENCIAS MÉDICAS [UNESCO] ,Ciencias de la salud ,Otorhinolaryngology ,Apoptosis ,UNESCO::CIENCIAS MÉDICAS ,biology.protein ,Cancer research ,Carcinoma, Squamous Cell ,Surgery ,Female ,Mouth Neoplasms ,biological phenomena, cell phenomena, and immunity ,Carcinogenesis - Abstract
Background: Apoptosis is an important mechanism that is responsible for the physiological deletion of harmful, damaged, or unwanted cells. Changed expression of apoptosis-related genes may lead to abnormal cell proliferation and finally to tumorigenesis. Our aims were to analyze the promoter methylation and gene expression profiles of FADD and FAS genes in risk of OSCC. Material and Methods: we analyze the promoter methylation status of FADD and FAS genes using Methylation - Specific PCR (MSP) in 86 OSCC tissues were kept in paraffin and 68 normal oral tissues applied as control. Also, FADD and FAS genes expression were analyzed in 19 cases and 20 normal specimens by Real-Time Reverse- Transcripts PCR. Results: Aberrant promoter methylation of FADD and FAS genes were detected in 12.79 % (11 of 86) and 60.46 % (52 of 86) of the OSCC cases, respectively, with a significant difference between cases and healthy controls for both FADD and FAS genes ( P
- Published
- 2014